Natixis’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Buy |
62,713
+42,962
| +218% | +$3.75M | 0.02% | 318 |
|
|
2025
Q1 | $1.34M | Sell |
19,751
-11,119
| -36% | -$752K | 0.01% | 483 |
|
|
2024
Q4 | $2.4M | Sell |
30,870
-126,994
| -80% | -$9.88M | 0.01% | 422 |
|
|
2024
Q3 | $10.6M | Buy |
157,864
+68,073
| +76% | +$4.56M | 0.06% | 207 |
|
|
2024
Q2 | $10.2M | Buy |
89,791
+81,791
| +1,022% | +$9.27M | 0.06% | 197 |
|
|
2024
Q1 | $1.11M | Buy |
8,000
+1,600
| +25% | +$222K | 0.01% | 496 |
|
|
2023
Q4 | $794K | Buy |
+6,400
| New | +$794K | 0.01% | 544 |
|
|
2023
Q1 | – | Sell |
-59,549
| Closed | -$6.74M | – | 1016 |
|
|
2022
Q4 | $6.74M | Buy |
59,549
+570
| +1% | +$64.5K | 0.04% | 306 |
|
|
2022
Q3 | $4.81M | Sell |
58,979
-21,223
| -26% | -$1.73M | 0.02% | 403 |
|
|
2022
Q2 | $5.99M | Sell |
80,202
-516,838
| -87% | -$38.6M | 0.02% | 390 |
|
|
2022
Q1 | $76.4M | Sell |
597,040
-145,796
| -20% | -$18.6M | 0.27% | 78 |
|
|
2021
Q4 | $99.7M | Buy |
742,836
+209,440
| +39% | +$28.1M | 0.34% | 48 |
|
|
2021
Q3 | $72.9M | Buy |
533,396
+228,208
| +75% | +$31.2M | 0.25% | 74 |
|
|
2021
Q2 | $32.6M | Buy |
305,188
+155,856
| +104% | +$16.6M | 0.14% | 143 |
|
|
2021
Q1 | $13.4M | Sell |
149,332
-141,764
| -49% | -$12.7M | 0.04% | 324 |
|
|
2020
Q4 | $26.9M | Buy |
+291,096
| New | +$26.9M | 0.1% | 206 |
|
|
2020
Q2 | – | Sell |
-175,692
| Closed | -$11.8M | – | 765 |
|
|
2020
Q1 | $11.8M | Buy |
175,692
+136,120
| +344% | +$9.16M | 0.09% | 182 |
|
|
2019
Q4 | $2.14M | Buy |
+39,572
| New | +$2.14M | 0.01% | 547 |
|
|
2018
Q4 | – | Sell |
-29,384
| Closed | -$1.05M | – | 716 |
|
|
2018
Q3 | $1.05M | Buy |
+29,384
| New | +$1.05M | 0.01% | 564 |
|
|
2017
Q3 | – | Sell |
-41,536
| Closed | -$760K | – | 1268 |
|
|
2017
Q2 | $760K | Buy |
+41,536
| New | +$760K | 0.01% | 451 |
|